Immunosuppressive regimen and interstitial fibrosis and tubules atrophy at 12 months postrenal transplant

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 6, 2012, Pages 1010-1017

  Gelens, Mariëlle A C J ^a   Steegh, Floor M E G ^a   van Hooff, Johannes P ^a   van Suylen, Robert Jan ^a   Nieman, Frederikus H M ^a   van Heurn, Lodewijk W E ^a   Peutz Kootstra, Carine J ^a   Christiaans, Maarten H L ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; STEROID; TACROLIMUS;

ADD ON THERAPY; ADULT; ARTICLE; CONTROLLED STUDY; DONOR; DRUG DOSE REDUCTION; FEMALE; FIBROSING ALVEOLITIS; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ATROPHY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; RENAL GRAFT DYSFUNCTION; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADULT; AGED; ATROPHY; BIOPSY; DRUG THERAPY, COMBINATION; FEMALE; FIBROSIS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOPHENOLIC ACID; NETHERLANDS; PROTEINURIA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; STEROIDS; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84862231537     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09030911     Document Type: Article

References (35)

1. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB: Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 346: 580-590, 2002
2. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK: Long-term survival in renal transplant recipients with graft function. Kidney Int 57: 307-313, 2000
3. Paul LC: Chronic allograft nephropathy: An update. Kidney Int 56: 783-793, 1999
4. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR: The natural history of chronic allograft nephropathy. N Engl J Med 349: 2326-2333, 2003
5. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Chapman JR, Allen RD: Delta analysis of posttransplantation tubulointerstitial damage. Transplantation 78: 434-441, 2004
6. Moreso F, Serón D, Carrera M, Gil-Vernet S, Cruzado JM, Hueso M, Fulladosa X, Ramos R, Ibernon M, Castelao AM, GrinyóJM: Baseline immunosuppression is associated with histological findings in early protocol biopsies. Transplantation 78: 1064-1068, 2004
7. Moreso F, Ibernon M, Gomà M, Carrera M, Fulladosa X, Hueso M, Gil-Vernet S, Cruzado JM, Torras J, GrinyóJM, Serón D: Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 6: 747-752, 2006
8. Lehtonen SR, Taskinen EI, Isoniemi HM: Histological alterations in implant and one-year protocol biopsy specimens of renal allografts. Transplantation 72: 1138-1144, 2001
9. Nankivell BJ, Fenton-Lee CA, Kuypers DR, Cheung E, Allen RD, O'Connell PJ, Chapman JR: Effect of histological damage on long-term kidney transplant outcome. Transplantation 71: 515-523, 2001
10. Serón D, Moreso F, Bover J, Condom E, Gil-Vernet S, Canas C, Fulladosa X, Torras J, Carrera M, GrinyóJM, Alsina J: Early protocol renal allograft biopsies and graft outcome. Kidney Int 51: 310-316, 1997
11. Servais A, Meas-Yedid V, Noë l LH, Martinez F, Panterne C, Kreis H, Zuber J, Timsit MO, Legendre C, Olivo-Marin JC, Thervet E: Interstitial fibrosis evolution on early sequential screening renal allograft biopsies using quantitative image analysis. Am J Transplant 11: 1456-1463, 2011
12. Snoeijs MG, Schaubel DE, Hené R, Hoitsma AJ, Idu MM, Ijzermans JN, Ploeg RJ, Ringers J, Christiaans MH, Buurman WA, van Heurn LW: Kidneys from donors after cardiac death provide survival benefit. J Am Soc Nephrol 21: 1015-1021, 2010
13. Anglicheau D, Loupy A, Lefaucheur C, Pessione F, Létourneau I, CôtéI, Gaha K, Noël LH, Patey N, Droz D, Martinez F, Zuber J, Glotz D, Thervet E, Legendre C: A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donors. Am J Transplant 8: 2325-2334, 2008
14. Snoeijs MG, Buurman WA, Christiaans MH, van Hooff JP, Goldschmeding R, van Suylen RJ, Peutz-Kootstra CJ, van Heurn LW: Histological assessment of preimplantation biopsies may improve selection of kidneys from old donors after cardiac death. Am J Transplant 8: 1844-1851, 2008
15. Gelens MA, Christiaans MH, van Heurn EL, van den Berg-Loonen EP, Peutz-Kootstra CJ, van Hooff JP: High rejection rate during calcineurin inhibitor-free and early steroid withdrawal immunosuppression in renal transplantation. Transplantation 82: 1221-1223, 2006
16. van Hooff JP, Squifflet JP, Wlodarczyk Z, Vanrenterghem Y, Paczek L: A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients. Transplantation 75: 1934-1939, 2003
17. Pawinski T, Hale M, Korecka M, Fitzsimmons WE, Shaw LM: Limited sampling strategy for the estimation ofmycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus. Clin Chem 48: 1497-1504, 2002
18. Smak Gregoor PJ, van Gelder T, van Besouw NM, van derMast BJ, IJzermans JN, Weimar W: Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction. Transplantation 70: 143-148, 2000
19. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Marcussen N, Mihatsch MJ, Nadasdy T, Nickerson P, Olsen TS, Papadimitriou JS, Randhawa PS, Rayner DC, Roberts I, Rose S, Rush D, Salinas-Madrigal S, Salomon DR, Sund S, Taskinen E, Trpkov K, Yamaguchi Y: The Banff 97 working classification of renal allograft pathology. Kidney Int 55: 713-723, 1999
20. Pöge U, Gerhardt T, Palmedo H, Klehr HU, Sauerbruch T, Woitas RP: MDRD equations for estimation of GFR in renal transplant recipients. Am J Transplant 5: 1306-1311, 2005
21. Furness PN, Taub N, Assmann KJ, Banfi G, Cosyns JP, Dorman AM, Hill CM, Kapper SK, Waldherr R, Laurinavicius A, Marcussen N, Martins AP, Nogueira M, Regele H, Seron D, Carrera M, Sund S, Taskinen EI, Paavonen T, Tihomirova T, Rosenthal R: International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am J Surg Pathol 27: 805-810, 2003
22. Snoeijs MG, Boonstra LA, Buurman WA, Goldschmeding R, van Suylen RJ, van Heurn LW, Peutz-Kootstra CJ: Histological assessment of pre-transplant kidney biopsies is reproducible and representative. Histopathology 56: 198-202, 2010
23. Nankivell BJ, Chapman JR, Bonovas G, Gruenewald SM: Oral cyclosporine but not tacrolimus reduces renal transplant blood flow. Transplantation 77: 1457-1459, 2004
24. Rowshani AT, Scholten EM, Bemelman F, Eikmans M, Idu M, Roos-van Groningen MC, Surachno JS, Mallat MJ, Paul LC, de Fijter JW, Bajema IM, ten Berge I, Florquin S: No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year. J Am Soc Nephrol 17: 305-312, 2006
25. Mota A, Arias M, Taskinen EI, Paavonen T, Brault Y, Legendre C, Claesson K, Castagneto M, Campistol JM, Hutchison B, Burke JT, Yilmaz S, Häyry P, Neylan JF; Rapamune Maintenance Regimen Trial: Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years. Am J Transplant 4: 953-961, 2004
26. Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF; SirolimusCONVERT Trial Study Group: Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation 87: 233-242, 2009
27. Gallon L, Perico N, Dimitrov BD, Winoto J, Remuzzi G, Leventhal J, Gaspari F, Kaufman D: Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. Am J Transplant 6: 1617-1623, 2006
28. Vitko S, Wlodarczyk Z, Kyllönen L, Czajkowski Z, Margreiter R, Backman L, Perner F, Rigotti P, Jaques B, Abramowicz D, Kessler M, Sanchez-Plumed J, Rostaing L, Rodger RS, Donati D, Vanrenterghem Y: Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: Results of a multicenter study. Am J Transplant 6: 531-538, 2006
29. Kumar MS, Heifets M, Moritz MJ, Saeed MI, Khan SM, Fyfe B, Sustento-Riodeca N, Daniel JN, Kumar A: Safety and efficacy of steroid withdrawal two days after kidney transplantation: analysis of results at three years. Transplantation 81: 832-839, 2006
30. Kaeberlein M, Kennedy BK: Hot topics in aging research: Protein translation and TOR signaling, 2010. Aging Cell 10: 185-190, 2011
31. Fogo AB: The targeted podocyte. J Clin Invest 121: 2142-2145, 2011
32. Yilmaz M, Nart A, Sen S, Tasli F, Uslu A, Hur E, Ozkahya M, Hoscoskun C, Toz H: Progression of graft fibrosis under mammalian target of rapamycin inhibitor-based regimen. Nephrology (Carlton) 15: 653-658, 2010
33. Schwarz A, Mengel M, Gwinner W, Radermacher J, Hiss M, Kreipe H, Haller H: Risk factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study. Kidney Int 67: 341-348, 2005
34. Lenihan CR, O'Kelly P, Mohan P, Little D, Walshe JJ, Kieran NE, Conlon PJ: MDRD-estimated GFR at one year post-renal transplant is a predictor of long-term graft function. Ren Fail 30: 345-352, 2008
35. Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP: Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 62: 311-318, 2002